miscsubjectsautonomous operating environment
Evidence review

Tesamorelin for Postherpetic Neuralgia: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-postherpetic`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-postherpetic

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-postherpetic/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

Postherpetic neuralgia (PHN) follows shingles (herpes zoster) reactivation of varicella-zoster virus. Nerve damage occurs in affected dermatomes. Axons degenerate. Myelin sheaths suffer. Distal tissues lose innervation. Muscle atrophy can follow if reinnervation lags. Chronic pain persists because repair pathways fail to restore normal signaling. This is degeneration outrunning repair at the peripheral nerve level.

Why Tesamorelin might help you

Tesamorelin stimulates growth hormone release via the GH axis. If your postherpetic issue includes failed axonal regeneration or muscle atrophy from denervation, this layer matters.

  1. GH and IGF-1 signaling support Schwann cell activity and axon growth in nerve injury models.
  2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.
  3. Reduced visceral fat is a separate documented effect but not directly tied to neural recovery here.

How these fit together

Single-compound focus. Tesamorelin maps to the GH axis / visceral fat layer. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

No human trials test tesamorelin specifically in postherpetic neuralgia (preclinical|mechanistic). One ongoing Phase 2 trial (NCT03150511) evaluates tesamorelin after peripheral nerve injury repair in humans; outcomes include axonal regeneration via MRI/EMG and functional recovery. Results remain unpublished as of 2026 (human|ongoing).

Animal studies show growth hormone improves sciatic nerve regeneration after transection in rats: increased axon and Schwann cell density, higher compound muscle action potential amplitude, and better treadmill performance (preclinical|animal).

A 2016 review summarizes GH/IGF-1 effects on multiple tissues in peripheral nerve injury, including reduced muscle atrophy (preclinical|review).

Tesamorelin reduces visceral adipose tissue in HIV patients per prior FDA data, but this does not address nerve repair (human|separate indication).

What scientists say

Researchers note GH-based therapies show multi-modal promise for peripheral nerve injuries through accelerated regeneration and atrophy limitation, distinct from single-pathway agents (mechanistic|review). They call for clinical translation but emphasize lack of approved indications for neuropathic pain syndromes like PHN.

What people say on Reddit

Scant discussion. One thread mentions thymosin peptides for potential nerve repair in PHN contexts; no direct tesamorelin reports (anecdotal|none).

What people say on X

No relevant posts identified linking tesamorelin to postherpetic neuralgia or shingles recovery (anecdotal|none).

What we do not know

Direct efficacy in PHN remains untested in humans. Optimal timing post-shingles, interaction with standard analgesics, and long-term nerve-specific outcomes lack data. Translation from traumatic nerve injury models to viral neuropathy is speculative.

Safety and limits

Tesamorelin carries documented effects on glucose metabolism and injection-site reactions from approved use. No PHN-specific safety data exist. Evidence base is early-stage for nerve applications overall.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 4 claims are extracted and stored on the object.
  • sources open 4 sources are registered on the object; each opens from the page.
  • claims bound 4 of 4 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/tesamorelin-postherpetic/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/tesamorelin-postherpetic/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/tesamorelin-postherpetic?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/tesamorelin-postherpetic/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Postherpetic neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain 9063649e77ac · verify chain · provenance

Key evidence

4 claims · tier-ranked · API
preclinical
GH treatment in rats after sciatic nerve transection increased axon/Schwann cell density and improved functional measures.
sources: s3
mechanistic
GH/IGF-1 therapies show multi-modal effects on nerve regeneration and muscle preservation in peripheral nerve injury reviews.
sources: s4
humanlow confidence
Ongoing Phase 2 trial NCT03150511 tests tesamorelin after peripheral nerve injury repair for axonal regeneration and functional recovery.
sources: s2
preclinicallow confidence
No human trials test tesamorelin specifically in postherpetic neuralgia.
sources: s1
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:15
Tesamorelin for Postherpetic Neuralgia: Evidence Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Postherpetic
Slug: tesamorelin-postherpetic
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerati
it output
{
  "slug": "tesamorelin-postherpetic",
  "title": "Tesamorelin for Postherpetic Neuralgia: Evidence Review",
  "body": "## What's breaking down\n\nPostherpetic neuralgia (PHN) follows shingles (herpes zoster) reactivation of varicella-zoster virus. Nerve damage occurs in affected dermatomes. Axons degenerate. Myelin sheaths suffer. Distal tissues lose innervation. Muscle atrophy can follow if reinnervation lags. Chronic pain persists because repair pathways fail to restore normal signaling. This is degeneration outrunning repair at the peripheral nerve level.\n\n## Why Tesamorelin might help you\n\nTesamorelin stimulates growth hormone release via the GH axis. If your postherpetic issue includes failed axonal regeneration or muscle atrophy from denervation, this layer matters.\n\n1. GH and IGF-1 signaling support Schwann cell activity and axon growth in nerve injury models.\n2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n3. Reduced visceral fat is a separate documented effect but not directly tied to neural recovery here.\n\n## How these fit together\n\nSingle-compound focus. Tesamorelin maps to the GH axis / visceral fat layer. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n- **Tesamorelin** → GH ax
bdc9116903e37af9
Machine verification: /api/articles/tesamorelin-postherpetic/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "GH treatment in rats after sciatic nerve transection increased axon/Schwann cell density and improved functional measures."?
ask tesamorelin-postherpetic claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "GH/IGF-1 therapies show multi-modal effects on nerve regeneration and muscle preservation in peripheral nerve injury reviews."?
ask tesamorelin-postherpetic claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Ongoing Phase 2 trial NCT03150511 tests tesamorelin after peripheral nerve injury repair for axonal regeneration and functional recovery."?
ask tesamorelin-postherpetic claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "No human trials test tesamorelin specifically in postherpetic neuralgia."?
ask tesamorelin-postherpetic claim c1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin for Postherpetic Neuralgia: Evidence Review — and what would you need me to tell you first?
ask tesamorelin-postherpetic condition gaps · paste includes §SELF
What good and bad outcomes are documented for Tesamorelin for Postherpetic Neuralgia: Evidence Review (studies vs anecdotes)?
ask tesamorelin-postherpetic good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Ftesamorelin-postherpetic%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/tesamorelin-postherpetic/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/tesamorelin-postherpetic/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3